These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3093332)

  • 1. In vitro active cyclophosphamide derivatives in cleansing procedures intended for autologous bone marrow transplantation.
    Manna A; Sparaventi G; Palazzi M; Porcellini A
    Haematologica; 1986; 71(3):257-61. PubMed ID: 3093332
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro purging of bone marrow with mafosfamide synergizes with in vivo chemotherapy to delay the hematological recovery in a murine model of autologous bone marrow transplantation.
    Lopez M; Mary JY; Sainteny F
    Exp Hematol; 1993 Feb; 21(2):311-8. PubMed ID: 8425567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential differentiation of murine CFU-S toward granulopoiesis and megakaryocytopoiesis after in vitro incubation of bone marrow with ASTA-Z 7557.
    Sainteny F; Lopez M; Mary JY; Frindel E
    Exp Hematol; 1987 Jul; 15(6):631-5. PubMed ID: 3297759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopharmacologic purging of breast cancer from bone marrow for autologous bone marrow transplantation.
    Shpall EJ; Anderson IC; Bast RC; Joines WT; Jones RB; Ross M; Edwards S; Eggleston S; Johnston C; Tepperberg M
    Prog Clin Biol Res; 1990; 333():321-35; discussion 336. PubMed ID: 2308989
    [No Abstract]   [Full Text] [Related]  

  • 5. Normal blast colony formation: an in vitro tool for monitoring human bone marrow 'purging'.
    Degliantoni G; Mangoni L; Rizzoli V
    Bone Marrow Transplant; 1986 Dec; 1(2):209-13. PubMed ID: 3332133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the protection of murine bone marrow stem cells by WR-2721 during in vitro treatment with mafosfamide.
    Jiang R; Bony V; Lopez M
    Prog Clin Biol Res; 1994; 389():23-9. PubMed ID: 7700906
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative in vitro effects of cyclophosphamide derivatives on murine bone marrow-derived stromal and hemopoietic progenitor cell classes.
    de Jong JP; Nikkels PG; Brockbank KG; Ploemacher RE; Voerman JS
    Cancer Res; 1985 Sep; 45(9):4001-5. PubMed ID: 3896474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-Hydroperoxycyclophosphamide treatment of stored bone marrow grafts.
    Davis JM; Schepers KG; Noga SJ; Jones RJ
    Prog Clin Biol Res; 1994; 389():3-7. PubMed ID: 7700912
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitative problems in bone marrow transplantation by peripheral blood stem cells.
    Serafimov-Dimitrov V
    Haematologia (Budap); 1986; 19(2):141-6. PubMed ID: 3530907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma interacts with mafosfamide toxicity to normal haematopoietic progenitor cells: impact on in vitro marrow purging.
    Giarratana MC; Gorin NC; Douay L
    Nouv Rev Fr Hematol (1978); 1995; 37(2):125-30. PubMed ID: 7644349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difference in kinetics of hematopoietic reconstitution between ALL and ANLL after autologous bone marrow transplantation with marrow treated in vitro with mafosfamide (ASTA Z 7557).
    Douay L; Laporte JP; Mary JY; Lopez M; Lemonnier MP; Stachowiak J; Benitez O; Deloux J; Najman A; Salmon C
    Bone Marrow Transplant; 1987 Jun; 2(1):33-43. PubMed ID: 3332155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro purging of leukemia and solid tumor cells by merocyanine 540.
    Manna A; Marchetti-Rossi MT; Porcellini A
    Haematologica; 1987; 72(2):177-9. PubMed ID: 3114075
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of long-term human marrow cultures to demonstrate progenitor cell precursors in marrow treated with 4-hydroperoxycyclophosphamide.
    Winton EF; Colenda KW
    Exp Hematol; 1987 Jul; 15(6):710-4. PubMed ID: 3595769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oxazaphosphorine cytostatics on granuloid progenitor cell (CFUc) proliferation in mice.
    Semont H; Hecquet C; Adolphe M; Deysson G
    Exp Hematol; 1982 Oct; 10(9):782-8. PubMed ID: 7173344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of the ability to purge tumor from murine bone marrow using clonogenic assays.
    Jones RJ; Colvin OM; Sensenbrenner LL
    Cancer Res; 1988 Jun; 48(12):3394-7. PubMed ID: 3285994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a combined treatment with ASTA-Z 7654 and VP16-213 in vitro in eradicating clonogenic tumor cells from human bone marrow.
    De Fabritiis P; Pulsoni A; Sandrelli A; Simone F; Amadori S; Meloni G; Mandelli F
    Bone Marrow Transplant; 1987 Oct; 2(3):287-98. PubMed ID: 3502785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of residual murine LPC-1 myeloma cells from bone marrow cell mixture after purging by 4-hydroperoxycyclophosphamide.
    Frondoza CG; Sinha S; Trivedi SM; Humphrey RL; Colvin OM
    Exp Hematol; 1987 Jul; 15(6):715-8. PubMed ID: 3297761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
    de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
    Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human granulocyte-colony stimulating factor: in vitro and in vivo effects on myelopoiesis.
    Welte K; Bonilla MA; Gabrilove JL; Gillio AP; Potter GK; Moore MA; O'Reilly RJ; Boone TC; Souza LM
    Blood Cells; 1987; 13(1-2):17-30. PubMed ID: 3311216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells.
    van Besien K; Margolin K; Champlin R; Forman S
    Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S54-8. PubMed ID: 9457395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.